You are here: Home 
Categories BPH
Categories BPH Hemodynamic effects of once-daily tadalafil in men with signs and symptoms of benign prostatic hyperplasia on concomitant α1-adrenergic antagonist therapy: Results of a multicenter randomized, double-blind, placebo-controlled trial - Abstract
Hemodynamic effects of once-daily tadalafil in men with signs and symptoms of benign prostatic hyperplasia on concomitant α1-adrenergic antagonist therapy: Results of a multicenter randomized, double-blind, placebo-controlled trial - Abstract
Published on 21 August 2012
OBJECTIVE:To investigate the safety of daily coadministration of α-blockers with tadalafil 5 mg in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia.
To read more, a FREE Urotoday registration is required. Click here to register or login above.To read UIJ content, a separate subscription is required.
Tags:
